deltatrials
Completed PHASE2 NCT01593124

Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

Sponsor: CONRAD

Conditions Vaginal Infections Vaginal Inflammation
Interventions Imiquimod Nonoxynol-9 Placebo
Updated 5 times since 2017 Last updated: Mar 30, 2015 Started: May 31, 2012 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

A PHASE2 clinical study on Vaginal Infections and Vaginal Inflammation, this trial is completed. The trial is conducted by CONRAD and has accumulated 5 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CONRAD
Data source: CONRAD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Norfolk, United States